Mazzarotto, Francesco
 Distribuzione geografica
Continente #
AS - Asia 976
NA - Nord America 889
EU - Europa 391
SA - Sud America 340
AF - Africa 38
OC - Oceania 4
Totale 2.638
Nazione #
US - Stati Uniti d'America 840
SG - Singapore 387
BR - Brasile 287
HK - Hong Kong 175
CN - Cina 152
VN - Vietnam 106
IT - Italia 69
DE - Germania 64
GB - Regno Unito 58
TR - Turchia 57
IE - Irlanda 44
RU - Federazione Russa 42
CA - Canada 26
AT - Austria 24
FI - Finlandia 23
AR - Argentina 20
BD - Bangladesh 20
IN - India 20
FR - Francia 15
MX - Messico 15
SE - Svezia 12
ZA - Sudafrica 12
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 9
IQ - Iraq 8
ES - Italia 7
JP - Giappone 7
MA - Marocco 7
UA - Ucraina 7
PL - Polonia 6
SA - Arabia Saudita 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
LT - Lituania 4
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
PY - Paraguay 3
AL - Albania 2
BE - Belgio 2
CZ - Repubblica Ceca 2
HN - Honduras 2
ID - Indonesia 2
IR - Iran 2
JO - Giordania 2
KH - Cambogia 2
KR - Corea 2
NG - Nigeria 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.638
Città #
Hong Kong 175
Singapore 168
Princeton 82
Ashburn 81
Fairfield 50
Los Angeles 49
The Dalles 48
Istanbul 47
Beijing 43
Dublin 42
Ho Chi Minh City 40
Houston 32
São Paulo 29
Redondo Beach 25
San Diego 24
Helsinki 23
Seattle 21
New York 19
Wilmington 19
Hanoi 18
Moscow 18
San Francisco 18
Dallas 17
Nuremberg 16
Des Moines 14
Villa Carcina 14
Belo Horizonte 13
Brescia 13
Toronto 13
Ann Arbor 12
Buffalo 12
London 12
Vienna 12
Woodbridge 12
Cambridge 10
Atlanta 9
Düsseldorf 9
Pontassieve 9
Stockholm 9
Munich 8
Orem 8
Tianjin 7
Brasília 6
Chicago 6
Curitiba 6
Denver 6
Dhaka 6
Guangzhou 6
Lauterbourg 6
Portsmouth 6
Tokyo 6
Bremen 5
Haiphong 5
Hải Dương 5
Johannesburg 5
Kyiv 5
Milan 5
Montreal 5
Quito 5
Rio de Janeiro 5
Romola 5
Santa Clara 5
Tashkent 5
Thái Bình 5
Baghdad 4
Biên Hòa 4
Boston 4
Brooklyn 4
Charlotte 4
Chennai 4
Fortaleza 4
Goiânia 4
Kilburn 4
Manchester 4
Mantova 4
Melbourne 4
Mexico City 4
Mumbai 4
Poplar 4
Sheffield 4
Warsaw 4
Ankara 3
Boardman 3
Bogotá 3
Buenos Aires 3
Caxias do Sul 3
Chiswick 3
Duque de Caxias 3
Frankfurt am Main 3
Guaratinguetá 3
Guarulhos 3
Ha Long 3
Hanover 3
Lahore 3
Niterói 3
Petrópolis 3
Phoenix 3
Querétaro 3
Salt Lake City 3
Salvador 3
Totale 1.544
Nome #
Genome-wide association testing beyond SNPs 104
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 71
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 71
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 68
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 64
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 64
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 63
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 63
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 62
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 60
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 60
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 60
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 59
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 58
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 58
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 57
Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin 56
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 55
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 55
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 54
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 53
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 52
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 52
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 51
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 51
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 51
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 51
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 49
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 49
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 49
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 48
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 48
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 47
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 45
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 45
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 45
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 44
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 44
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 44
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 44
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 43
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 43
Titin-truncating variants affect heart function in disease cohorts and the general population 43
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 42
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 42
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 42
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 39
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 36
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 36
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 30
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy 30
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 25
Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy 20
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 8
Totale 2.703
Categoria #
all - tutte 24.465
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 127 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025845 1 6 6 85 88 49 71 84 80 97 183 95
2025/20261.220 191 266 155 322 174 112 0 0 0 0 0 0
Totale 2.703